Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Characterizing clinician communication with patients about lecanemab: A qualitative study of clinicians across seven academic medical centers 2025-07-01
  2. Effects of the Davos Alzheimer's Collaborative early detection of cognitive impairment program on clinician attitudes, engagement, and confidence 2025-02-04
  3. Clinical Utility of an Alzheimer's Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study 2025-01-13

Studies

3 studies carry this tag.

Date range

2025

Top journals

  • Alzheimer's & dementia (New York, N. Y.) 1
  • Diagnostics (Basel, Switzerland) 1
  • The journal of prevention of Alzheimer's disease 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Characterizing clinician communication with patients about lecanemab: A qualitative study of clinicians across seven academic medical centers

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer's & dementia (New York, N. Y.) 2025-07-01 Treatments

    Preliminary insights about how clinicians communicate tradeoffs can guide future shared decision-making interventions for mAbs.

  2. Effects of the Davos Alzheimer's Collaborative early detection of cognitive impairment program on clinician attitudes, engagement, and confidence

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. The journal of prevention of Alzheimer's disease 2025-02-04 Cognitive tests and assessment

    The implementation of digital cognitive assessment tools and a blood biomarker test was associated with an increase in healthcare professionals' confidence in diagnosing and managing patients with cognitive impairment in primary care and non-specialty settings.

  3. Clinical Utility of an Alzheimer's Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Diagnostics (Basel, Switzerland) 2025-01-13 Biomarkers

    Patients had a median age of 74, 53% were female, and 28% were traditionally under-represented in Black, Hispanic, and Asian groups.

All topic tags with their study counts